Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : DGX    source : Www.biospace.com    save search

Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
Published: 2024-04-02 (Crawled : 15:30) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: -0.13% H: 0.0% C: -1.72%

test genetic diagnostics
Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease
Published: 2024-03-26 (Crawled : 12:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: 0.26% H: 0.1% C: -0.58%

disease test blood alzheimer's imaging study
Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024
Published: 2024-03-19 (Crawled : 22:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: 0.12% H: 1.28% C: 0.59%

first diagnostics financial results
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Published: 2024-02-15 (Crawled : 12:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: 0.22% H: 0.7% C: -1.77%

million cancer funding platform
Quest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share
Published: 2024-02-01 (Crawled : 14:30) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: -3.41% H: 4.47% C: 2.52%

year diagnostics financial
Fitbit and Quest Diagnostics Collaborate to Advance Research on the Use of Wearable Devices to Improve Metabolic Health
Published: 2024-01-17 (Crawled : 20:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: -0.13% H: 1.38% C: 0.03%

metabolic health research diagnostics
Quest Diagnostics and Ultima Collaborate to Scale Ultima’s Technology in Fast-Growing Minimal Residual Disease and Whole Genome Sequencing
Published: 2024-01-09 (Crawled : 20:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: 0.28% H: 0.65% C: 0.08%

disease technology diagnostics
Quest Diagnostics Launches New 88-Compound Novel Psychoactive Substance Test Panel
Published: 2023-12-19 (Crawled : 17:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: 0.17% H: 0.59% C: 0.29%

test diagnostics
Quest Diagnostics and Scipher Medicine Collaborate to Scale Precision Medicine Access for Patients with Rheumatoid Arthritis
Published: 2023-11-28 (Crawled : 15:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: 0.18% H: 0.78% C: 0.12%

diagnostics
Quest Diagnostics Reports Third Quarter 2023 Financial Results; Updates Guidance for Full Year 2023
Published: 2023-10-24 (Crawled : 12:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: 1.0% H: 1.13% C: 0.75%

year diagnostics financial
Quest Diagnostics Releases 2022 Corporate Responsibility Report
Published: 2023-09-07 (Crawled : 12:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: 0.34% H: 0.56% C: -0.36%

report diagnostics
Quest Diagnostics Reports Second Quarter 2023 Financial Results; Updates Guidance for Full Year 2023
Published: 2023-07-26 (Crawled : 11:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: -4.6% H: 2.16% C: -1.46%

year diagnostics financial
Quest Diagnostics Launches Novel Prostate Cancer Test Aimed at Improving Diagnosis and Grading
Published: 2023-07-13 (Crawled : 14:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: 0.09% H: 0.47% C: -0.21%

test cancer diagnostics
Quest Diagnostics Named a 'Best Place to Work for Disability Inclusion' for Sixth Consecutive Year
Published: 2023-07-13 (Crawled : 12:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: 0.09% H: 0.47% C: -0.21%

work year diagnostics
Quest Diagnostics to Release Second Quarter 2023 Financial Results on July 26, 2023
Published: 2023-06-21 (Crawled : 21:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: -0.08% H: 1.07% C: 0.53%

diagnostics financial results
Quest Diagnostics Extends Alzheimer's Disease Portfolio with New AI-Powered Test Service from uMETHOD Health
Published: 2023-05-04 (Crawled : 12:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: -0.62% H: 0.07% C: -0.24%

disease test service health alzheimer's diagnostics
Quest Diagnostics to Acquire Haystack Oncology, Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio
Published: 2023-04-27 (Crawled : 12:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: 0.01% H: 0.0% C: -3.98%

cancer care acquire technology diagnostics
Quest Diagnostics to Release First Quarter 2023 Financial Results on April 27, 2023
Published: 2023-04-04 (Crawled : 22:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: 0.35% H: 0.03% C: -1.38%

diagnostics financial results
Quest Diagnostics Unveils Advanced Transplant Diagnostic Services Featuring Anywhere-Access in the United States
Published: 2023-03-22 (Crawled : 15:20) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: 0.29% H: 0.68% C: -1.45%

services diagnostic diagnostics
Cleveland Diagnostics Announces Agreement with Quest Diagnostics to Expand Patient Access to IsoPSA® Prostate Cancer Testing
Published: 2023-02-13 (Crawled : 16:00) - biospace.com/
DGX | $128.44 2.01% 0.0% 1.6M twitter stocktwits trandingview |
Health Services
| | O: 0.09% H: 0.96% C: 0.92%

isopsa diagnostics agreement cancer prostate cancer
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.